Search

Your search keyword '"Jooste V"' showing total 266 results
Start Over Author "Jooste V"
266 results on '"Jooste V"'

1. Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study

Author

Van Eycken, L., Henau, K., Grozeva, T., Valerianova, Z., Innos, K., Mägi, M., Bouvier, V., Launoy, G., Robaszkiewicz, M., Bouvier, A.M., Jooste, V., Babaev, V., Katalinic, A., Ólafsdóttir, E.J., Tryggvadóttir, L., Amati, C., Baili, P., Bonfarnuzzo, S., Margutti, C., Meneghini, E., Minicozzi, P., Moretti, G., Sant, M., Cirilli, C., Carrozzi, G., Spata, E., Tumino, R., Rossi, P. Giorgi, Vicentini, M., Stracci, F., Bianconi, F., Contiero, P., Tagliabue, G., Kycler, W., Oko, M., Macek, P., Smok-Kalwat, J., Bielska-Lasota, M., Bento, M.J., Rodrigues, J, Mayer-da-Silva, A., Miranda, A., Primic-Žakelj, M., Jarm, K., Almar, E., Mateos, A., Bidaurrazaga, J., de la Cruz, M., Alberich, C., Torrella-Ramos, A., García, J.M. Díaz, Marcos-Navarro, AI, Carmona-Garcia, C., Marcos-Gragera, R., Luque-Fernandez, M.A., Sánchez-Pérez, M.J., Ardanaz, E., Guevara, M., Bouchardy, C., Fournier, E., Bouvier, Anne-Marie, Jooste, Valérie, Sanchez-Perez, Maria José, Bento, Maria José, Rocha Rodrigues, Jessica, Marcos-Gragera, Rafael, Carmona-Garcia, Maria Carmen, Luque-Fernandez, Miguel Angel, Minicozzi, Pamela, Bouvier, Véronique, Innos, Kaire, and Sant, Milena

Published
2021
Full Text
View/download PDF

2. Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study

Author

Van Eycken, L., Henau, K., Grozeva, T., Valerianova, Z., Innos, K., Mägi, M., Bouvier, V., Launoy, G., Jooste, V., Normand, S., Robaszkiewicz, M., Bouvier, A.-M., Faivre, J., Babaev, V., Katalinic, A., Ólafsdóttir, E.J., Tryggvadóttir, L., Amati, C., Baili, P., Bonfarnuzzo, S., Meneghini, E., Minicozzi, P., Moretti, G., Sant, M., Cirilli, C., Carrozzi, G., Spata, E., Tumino, R., Giorgi Rossi, P., Vicentini, M., Stracci, F., Bianconi, F., Contiero, P., Tagliabue, G., Kycler, W., Oko, M., Macek, P., Smok-Kalwat, J., Bielska-Lasota, M., Bento, M.J., Castro, C., Mayer-da-Silva, A., Miranda, A., Primic Žakelj, M., Jarm, K., Almar, E., Mateos, A., Bidaurrazaga, J., de la Cruz, M., Alberich, C., Torrella-Ramos, A., Marcos Navarro, A.I., Jiménez Chillarón, R., Carmona-Garcia, M.C., Marcos-Gragera, R., Rodriguez-Barranco, M., Sánchez, M.J., Ardanaz, E., Guevara, M., Bouchardy, C., Fournier, E., Minicozzi, Pamela, Vicentini, Massimo, Innos, Kaire, Castro, Clara, Guevara, Marcela, Stracci, Fabrizio, Carmona-Garcia, M<ce:sup loc='post">a</ce:sup>Carmen, Rodriguez-Barranco, Miguel, Vanschoenbeek, Katrijn, Rapiti, Elisabetta, Katalinic, Alexander, Marcos-Gragera, Rafael, Van Eycken, Liesbet, Sánchez, Maria José, Bielska-Lasota, Magdalena, Rossi, Paolo Giorgi, and Sant, Milena

Published
2020
Full Text
View/download PDF

7. Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials

Author

Vener, C., Rossi, S., Minicozzi, P., Marcos-Gragera, R., Poirel, H. A., Maynadie, M., Troussard, X., Pravettoni, G., De Angelis, R., Sant, M., Hackl, M., Van Eycken, E., Valerianova, Z., Sekerija, M., Pavlou, P., Dusek, L., Storm, H., Magi, M., Innos, K., Malila, N., Pitkaniemi, J., Velten, M., Bouvier, A. M., Jooste, V., Guizard, A. V., Launoy, G., Yonli, S. D., Woronoff, A. S., Nousbaum, J. B., Coureau, G., Monnereau, A., Baldi, I., Hammas, K., Tretarre, B., Colonna, M., Plouvier, S., D'Almeida, T., Molinie, F., Cowppli-Bony, A., Bara, S., Schvartz, C., Defossez, G., Lapotre-Ledoux, B., Grosclaude, P., Luttmann, S., Stabenow, R., Nennecke, A., Kieschke, J., Zeissig, S., Holleczek, B., Katalinic, A., Birgisson, H., Murray, D., Walsh, P. M., Mazzoleni, G., Vittadello, F., Cuccaro, F., Galasso, R., Sampietro, G., Rosso, S., Magoni, M., Ferrante, M., Sardo, A. S., Gambino, M. L., Ballotari, P., Giacomazzi, E., Ferretti, S., Caldarella, A., Manneschi, G., Gatta, G., Baili, P., Berrino, F., Botta, L., Trama, A., Lillini, R., Bernasconi, A., Bonfarnuzzo, S., Didone, F., Lasalvia, P., Del Monego, G., Magri, M. C., Buratti, L., Serraino, D., Dal Maso, L., Capocaccia, R., Demuru, E., Di Benedetto, C., Santaquilani, M., Venanzi, S., Filiberti, R. A., Iacovacci, S., Gennaro, V., Russo, A. G., Spagnoli, G., D'Oro, L. C., Fusco, M., Vitale, M. F., Usala, M., Vitale, F., Michiara, M., Chiranda, G., Cascone, G., Spata, E., Mangone, L., Falcini, F., Cavallo, R., Piras, D., Madeddu, A., Bella, F., Fanetti, A. C., Minerba, S., Candela, G., Scuderi, T., Rizzello, R. V., Stracci, F., Tagliabue, G., Rugge, M., Brustolin, A., Pildava, S., Smailyte, G., Azzopardi, M., Johannesen, T. B., Didkowska, J., Wojciechowska, U., Bielska-Lasota, M., Pais, A., Pontes, J. L., Miranda, A., Diba, C. S., Zadnik, V., Zagar, T., Escudero, C. S. -C., Sureda, P. F., de Munain, A. L., De-La-cruz, M., Rojas, M. D., Aleman, A., Vizcaino, A., Sanchez, M. J., Chirlaque, M. D., Eslava, M. G., Ardanaz, E., Galceran, J., Carulla, M., Bergeron, Y., Bouchardy, C., Mousavi, S. M., Bordoni, A., Visser, O., Rashbass, J., Gavin, A., Morrison, D., and Huws, D. W.

Subjects
Cancer Research, Survival, real-world data, randomized controlled trials (RCTs), tyrosine kinase inhibitor (TKI), population-based studies, Tyrosine kinase inhibitor (TKI), Randomized controlled trials (RCTs), survival, Real-world data, Europe, Oncology, cancer registries, chronic myeloid leukemia (CML), Chronic myeloid leukemia (CML), Cancer registries, Population-based studies
Abstract

This study was funded by the Compagnia di San Paolo, the Cariplo Foundation and the European Commission (grant number 801520 HP-JA-2017, Innovative Partnership for Action Against Cancer, iPAAC Joint Action). The sources of the funding played no role in designing the study, collecting, analyzing, or interpreting the data, writing the report, or deciding whether or not to submit the article for publication. This research was (partially) funded by Italian Ministry of Health "Ricerca Corrente" funds. Tyrosine kinase inhibitors (TKIs) have been improving the prognosis of patients with chronic myeloid leukemia (CML), but there are still large differences in survival among European countries. This raises questions on the added value of results from population-based studies, which use real-world data, compared to results of randomized controlled trials (RCTs) involving patients with CML. There are also questions about the extent of the findings on RCTs effectiveness for patients in the general population. We compare survival data extracted from our previous systematic review and meta-analysis of CML RCTs with the latest updated population-based survival data of EUROCARE-6, the widest collaborative study on cancer survival in Europe. The EUROCARE-6 CML survival estimated in patients (15-64 years) diagnosed in 2000-2006 vs. 2007-2013 revealed that the prognostic improvement highlighted by RCTs was confirmed in real-world settings, too. The study shows, evaluating for the first time all European regions, that the optimal outcome figures obtained in controlled settings for CML are also achievable (and indeed achieved) in real-world settings with prompt introduction of TKIs in daily clinical practice. However, some differences still persist, particularly in Eastern European countries, where overall survival values are lower than elsewhere, probably due to a delayed introduction of TKIs. Our results suggest an insufficient adoption of adequate protocols in daily clinical practice in those countries where CML survival values remain lower in real life than the values obtained in RCTs. New high-resolution population-based studies may help to identify failures in the clinical pathways followed there.

Published
2022

11. Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†

Author

Bellera, C. A., Penel, N., Ouali, M., Bonvalot, S., Casali, P. G., Nielsen, O. S., Delannes, M., Litière, S., Bonnetain, F., Dabakuyo, T. S., Benjamin, R. S., Blay, J.-Y., Bui, B. N., Collin, F., Delaney, T. F., Duffaud, F., Filleron, T., Fiore, M., Gelderblom, H., George, S., Grimer, R., Grosclaude, P., Gronchi, A., Haas, R., Hohenberger, P., Issels, R., Italiano, A., Jooste, V., Krarup-Hansen, A., Le Péchoux, C., Mussi, C., Oberlin, O., Patel, S., Piperno-Neumann, S., Raut, C., Ray-Coquard, I., Rutkowski, P., Schuetze, S., Sleijfer, S., Stoeckle, E., Van Glabbeke, M., Woll, P., Gourgou-Bourgade, S., and Mathoulin-Pélissier, S.

Published
2015
Full Text
View/download PDF

14. Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study

Author

Bouvier, Anne-Marie, primary, Jooste, Valérie, additional, Sanchez-Perez, Maria José, additional, Bento, Maria José, additional, Rocha Rodrigues, Jessica, additional, Marcos-Gragera, Rafael, additional, Carmona-Garcia, Maria Carmen, additional, Luque-Fernandez, Miguel Angel, additional, Minicozzi, Pamela, additional, Bouvier, Véronique, additional, Innos, Kaire, additional, Sant, Milena, additional, Van Eycken, L., additional, Henau, K., additional, Grozeva, T., additional, Valerianova, Z., additional, Innos, K., additional, Mägi, M., additional, Bouvier, V., additional, Launoy, G., additional, Robaszkiewicz, M., additional, Bouvier, A.M., additional, Jooste, V., additional, Babaev, V., additional, Katalinic, A., additional, Ólafsdóttir, E.J., additional, Tryggvadóttir, L., additional, Amati, C., additional, Baili, P., additional, Bonfarnuzzo, S., additional, Margutti, C., additional, Meneghini, E., additional, Minicozzi, P., additional, Moretti, G., additional, Sant, M., additional, Cirilli, C., additional, Carrozzi, G., additional, Spata, E., additional, Tumino, R., additional, Rossi, P. Giorgi, additional, Vicentini, M., additional, Stracci, F., additional, Bianconi, F., additional, Contiero, P., additional, Tagliabue, G., additional, Kycler, W., additional, Oko, M., additional, Macek, P., additional, Smok-Kalwat, J., additional, Bielska-Lasota, M., additional, Bento, M.J., additional, Rodrigues, J, additional, Mayer-da-Silva, A., additional, Miranda, A., additional, Primic-Žakelj, M., additional, Jarm, K., additional, Almar, E., additional, Mateos, A., additional, Bidaurrazaga, J., additional, de la Cruz, M., additional, Alberich, C., additional, Torrella-Ramos, A., additional, García, J.M. Díaz, additional, Marcos-Navarro, AI, additional, Carmona-Garcia, C., additional, Marcos-Gragera, R., additional, Luque-Fernandez, M.A., additional, Sánchez-Pérez, M.J., additional, Ardanaz, E., additional, Guevara, M., additional, Bouchardy, C., additional, and Fournier, E., additional

Published
2021
Full Text
View/download PDF

16. Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study

Author

Minicozzi, Pamela, primary, Vicentini, Massimo, additional, Innos, Kaire, additional, Castro, Clara, additional, Guevara, Marcela, additional, Stracci, Fabrizio, additional, Carmona-Garcia, MaCarmen, additional, Rodriguez-Barranco, Miguel, additional, Vanschoenbeek, Katrijn, additional, Rapiti, Elisabetta, additional, Katalinic, Alexander, additional, Marcos-Gragera, Rafael, additional, Van Eycken, Liesbet, additional, Sánchez, Maria José, additional, Bielska-Lasota, Magdalena, additional, Rossi, Paolo Giorgi, additional, Sant, Milena, additional, Van Eycken, L., additional, Henau, K., additional, Grozeva, T., additional, Valerianova, Z., additional, Innos, K., additional, Mägi, M., additional, Bouvier, V., additional, Launoy, G., additional, Jooste, V., additional, Normand, S., additional, Robaszkiewicz, M., additional, Bouvier, A.-M., additional, Faivre, J., additional, Babaev, V., additional, Katalinic, A., additional, Ólafsdóttir, E.J., additional, Tryggvadóttir, L., additional, Amati, C., additional, Baili, P., additional, Bonfarnuzzo, S., additional, Meneghini, E., additional, Minicozzi, P., additional, Moretti, G., additional, Sant, M., additional, Cirilli, C., additional, Carrozzi, G., additional, Spata, E., additional, Tumino, R., additional, Giorgi Rossi, P., additional, Vicentini, M., additional, Stracci, F., additional, Bianconi, F., additional, Contiero, P., additional, Tagliabue, G., additional, Kycler, W., additional, Oko, M., additional, Macek, P., additional, Smok-Kalwat, J., additional, Bielska-Lasota, M., additional, Bento, M.J., additional, Castro, C., additional, Mayer-da-Silva, A., additional, Miranda, A., additional, Primic Žakelj, M., additional, Jarm, K., additional, Almar, E., additional, Mateos, A., additional, Bidaurrazaga, J., additional, de la Cruz, M., additional, Alberich, C., additional, Torrella-Ramos, A., additional, Marcos Navarro, A.I., additional, Jiménez Chillarón, R., additional, Carmona-Garcia, M.C., additional, Marcos-Gragera, R., additional, Rodriguez-Barranco, M., additional, Sánchez, M.J., additional, Ardanaz, E., additional, Guevara, M., additional, Bouchardy, C., additional, and Fournier, E., additional

Published
2020
Full Text
View/download PDF

21. Impact pronostique de la concentration de 3-hydroxymyristate sur la survie des patients atteints de cirrhose alcoolique ou virale

Author

Granconato, L., primary, Pais de Barros, J.-P., additional, Mouillot, T., additional, Lagrost, L., additional, Bernard-Chabert, B., additional, Thieffin, G., additional, Jouve, J.-L., additional, Bronowicki, J.-P., additional, Richou, C., additional, Di Martino, V., additional, Doffoel, M., additional, Binquet, C., additional, Petit, J.-M., additional, Minello, A., additional, Latournerie, M., additional, Hillon, P., additional, Cottet, V., additional, Sgro, C., additional, Trechot, P., additional, Valnet-Rabier, M.-B., additional, Trenque, T., additional, Tebacher-Alt, M., additional, Faivre, J., additional, Masson, D., additional, Delmas, D., additional, Duvillard, L., additional, Guéant, J.-L., additional, Habersetzer, F., additional, Jooste, V., additional, Manfait, M., additional, Oudet, P., additional, Sockalingum, G.D., additional, and Vuitton, D., additional

Published
2019
Full Text
View/download PDF

24. Data quality in rare cancers registraton: The report of the RARECARE data quality study

Author

Trama, A., Marcos-Gragera, R., Perez, M. J. S., van der Zwan, J. M., Ardanaz, E., Bouchardy, C., Melchor, J. M., Martinez, C., Capocaccia, R., Vicentini, M., Siesling, S., Gatta, G., Zielonk, N., Van Eycken, E., Henau, K., Magi, M., Bouvier, A. M., Jooste, V., Faivre, J., Maynadie, M., Manivet, I., Comber, H., Deady, S., Bellu, F., Dal Cappello, T., Ferretti, S., Vercelli, M., Quaglia, A., Federico, M., Cirilli, C., Fusco, M., Michiara, M., Sgargi, P., Giacomin, A., Tumino, R., Cilia, S., Spata, E., Mangone, L., Cinzia, S., Falcini, F., Giorgetti, S., Piffer, S., Franchini, S., Crocetti, E., Caldarella, A., Tagliabue, G., Zambon, P., Fiore, A. R., Dei Tos, A. P., De Angelis, R., England, K., Gozdz, S., Mezyk, R., Zwierko, M., Bielska-Lasota, M., Slowinski, J., Primic-Zakelj, M., Skrlec, F., Mateos, A., Bidaurrazaga, J., Galceran, J., Diaz Garcia, J. M., Martinez-Garcia, C., Sanchez Perez, M. J., Adolfsson, J., Usel, M., Ess, S. M., Spitale, A., Bordoni, A., Konzelmann, I., Visser, O., Otter, R., and Health Technology & Services Research

Subjects
0301 basic medicine, Male, Cancer Research, medicine.medical_specialty, media_common.quotation_subject, Data quality registraton, Populaton-based cancer registry, Rare cancers, Europe, Female, Humans, Neoplasms, Rare Diseases, Data Accuracy, Registries, 03 medical and health sciences, 0302 clinical medicine, Data accuracy, medicine, Medical physics, Quality (business), media_common, ddc:613, Gynecology, business.industry, Cancer, General Medicine, medicine.disease, 22/4 OA procedure, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Data quality, business
Abstract

Purpose Rare cancers represent 22% of all tumors in Europe; however, the quality of the data of rare cancers may not be as good as the quality of data for common cancer. The project surveillance of rare cancers in Europe (RARECARE) had, among others, the objective of assessing rare cancer data quality in population-based cancer registries (CRs). Eight rare cancers were considered: mesothelioma, liver angiosarcoma, sarcomas, tumors of oral cavity, CNS tumors, germ cell tumors, leukemia, and malignant digestive endocrine tumors. Methods We selected data on 18,000 diagnoses and revised, on the basis of the pathologic and clinical reports (but not on pathologic specimens), unspecified morphology and topography codes originally attributed by CR officers and checked the quality of follow-up of long-term survivors of poor prognosis cancers. Results A total of 38 CRs contributed from 13 European countries. The majority of unspecified morphology and topography cases were confirmed as unspecified. The few unspecified cases that, after the review, changed to a more specific diagnosis increased the incidence of the common cancer histotypes. For example, 11% of the oral cavity epithelial cancers were reclassified from unspecified to more specific diagnoses: 8% were reclassified as squamous cell carcinoma (commoner) and only 1% as adenocarcinoma (rarer). The revision confirmed the majority of long-term survivors revealing a relative high proportion of mesothelioma long-term survivors. The majority of appendix carcinoids changed behavior from malignant to borderline lesions. Conclusions Our study suggests that the problem of poorly specified morphology and topography cases is mainly one of difficulty in reaching a precise diagnosis. The awareness of the importance of data quality for rare cancers should increase among registrars, pathologists, and clinicians.

Published
2017

26. Impact pronostique de la concentration de 3-hydroxymyristate sur la survie des patients atteints de cirrhose alcoolique ou virale

Author

Hillon, P., Bronowicki, J.-P., Di Martino, V., Doffoel, M., Thieffin, G., Sgro, C., Trechot, P., Valnet-Rabier, M.-B., Trenque, T., Tebacher-Alt, M., Faivre, J., Masson, D., Delmas, D., Duvillard, L., Guéant, J.-L., Habersetzer, F., Jooste, V., Manfait, M., Oudet, P., Sockalingum, G.D., Vuitton, D., Granconato, L., Pais de Barros, J.-P., Mouillot, T., Lagrost, L., Bernard-Chabert, B., Jouve, J.-L., Richou, C., Binquet, C., Petit, J.-M., Minello, A., Latournerie, M., and Cottet, V.

Published
2019
Full Text
View/download PDF

31. Conditional Relative Survival of Cancer Patients and Conditional Probability of Death

Author

Bouvier, A.-M., Remontet, L., Hédelin, L., Launoy, G., Jooste, V., Grosclaude, P., Belot, A., Lacour, B., Esteve, J., Bossard, Nadine, Faivre, J., Francim,, Biostatistiques santé, Département biostatistiques et modélisation pour la santé et l'environnement [LBBE], Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), and Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)

Subjects
[SDV.OT]Life Sciences [q-bio]/Other [q-bio.OT]
Abstract

BACKGROUND: Little information is available on the conditional probabilities of death among patients who survive for >5 years after a diagnosis with cancer. The objective of this study was to estimate the conditional probabilities of death for breast cancer, prostate cancer, colorectal cancer, and lung cancer in France. METHODS: The study included data from the French Network of Cancer Registries from 205,562 patients aged 4% at 10 years. During the 3 years after diagnosis, the probability of death was greater for older patients with breast cancer; then, it decreased less for younger patients compared with older patients, leading to a greater conditional probability of death among younger patients at 4 years and up to 10 years. The annual probability of death in patients with lung cancer decreased for both sexes but remained substantially higher for men than for women, reaching approximately 8% and 5%, respectively, at 10 years. CONCLUSIONS: Further studies would facilitate a better understanding of the observed differences in relative survival within European countries

Published
2009

32. Hazard regression model and cure rate model in colon cancer relative survival trends: are they telling the same story?

Author

Bejan-Angoulvant, T., Bouvier, A.-M., Bossard, Nadine, Belot, A., Jooste, V., Launoy, G., Remontet, L., Evaluation et modélisation des effets thérapeutiques, Département biostatistiques et modélisation pour la santé et l'environnement [LBBE], Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS), and Biostatistiques santé

Subjects
[SDV.OT]Life Sciences [q-bio]/Other [q-bio.OT]
Published
2008

37. 712 PNPLA 3 RS738409 GG HOMOZYGOTE STATUS IS ASSOCIATED WITH INCREASED RISK OF HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS

Author

Hamza, S., primary, Petit, J.M., additional, Masson, D., additional, Jooste, V., additional, Binquet, C., additional, Sgro, C., additional, Guiu, B., additional, Bronowicki, J.P., additional, Thieffin, G., additional, Di Martino, V., additional, Doffoel, M., additional, Barraud, H., additional, Richou, C., additional, Jouve, J.L., additional, Raab, J.J., additional, Bouvier, A.M., additional, Cottet, V., additional, Verges, B., additional, Minello, A., additional, Kopp, C. Bonithon, additional, and Hillon, P., additional

Published
2012
Full Text
View/download PDF

38. PO31 Le contenu hépatique en graisse est associé à une augmentation de la synthèse du cholestérol chez les patients diabétiques de type 2

Author

Petit, J.M., primary, Guiu, B., additional, Brindisi, M.C., additional, Duvillard, L., additional, Bouillet, B., additional, Rollot, F., additional, Jooste, V., additional, Verier, A.C., additional, Crevisy, E., additional, Athias, A., additional, Habchi, M., additional, Hillon, P., additional, Cercueil, J.P., additional, and Verges, B., additional

Published
2012
Full Text
View/download PDF

40. Statut mutationnel du gène KRAS dans le cancer colorectal humain : évaluation de trois méthodes alternatives de détection des mutations sur tissus fixés et cryoconservés

Author

Meilhac, C., primary, De Bermont, J., additional, Tournier, B., additional, Degrolard, E., additional, Jooste, V., additional, Martin, L., additional, Bouvier, A.-M., additional, Lepage, C., additional, Faivre, J., additional, Chapusot, C., additional, and Piard, F., additional

Published
2011
Full Text
View/download PDF

44. Immunogenic death of colon cancer cells treated with oxaliplatin

Author

Tesniere, A, primary, Schlemmer, F, additional, Boige, V, additional, Kepp, O, additional, Martins, I, additional, Ghiringhelli, F, additional, Aymeric, L, additional, Michaud, M, additional, Apetoh, L, additional, Barault, L, additional, Mendiboure, J, additional, Pignon, J-P, additional, Jooste, V, additional, van Endert, P, additional, Ducreux, M, additional, Zitvogel, L, additional, Piard, F, additional, and Kroemer, G, additional

Published
2009
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results